Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Frequent homozygous deletions CDKN2A locus somatic cancer tissues∨derfield=date∨derval=DESC" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Frequent homozygous deletions CDKN2A locus somatic cancer tissues∨derfield=date∨derval=DESC for you to read. Along with our medical data and news we also list Frequent homozygous deletions CDKN2A locus somatic cancer tissues∨derfield=date∨derval=DESC Clinical Trials, which are updated daily. BioPortfolio also has a large database of Frequent homozygous deletions CDKN2A locus somatic cancer tissues∨derfield=date∨derval=DESC Companies for you to search.
The growth and aging of the population combined with advances in the early detection and treatment of cancer have resulted in a growing population of survivors across the nation, according to a study from the American Cancer Society and the National Cancer Institute.
Shanghai Fosun Long March Medical Science struck a deal to bring the Nu.Q(TM) diagnostic platform developed by Belgium's VolitionRx to China. The two companies have already started a China clinical trial of a lung cancer diagnostic as the first application. Fosun Long March is the investment platform of the in-vitro diagnostics division of Fosun Pharma. In a China trial expected to be completed th...
Mother had double mastectomy after cancer diagnosis mistake The TimesMum told cancer diagnosis was WRONG after undergoing chemotherapy and having breast removed Daily RecordMum, 28, had chemotherapy and mastectomy only to be told she did not have cancer Mirror.co.ukStoke-on-Trent mum's cancer misdiagnosis down to 'human error' BBC NewsMum has double mastectomy and chemo before docs admit they ...
Dr Luis Raez speaks to ecancer at the ASCO Direct Highlights™ Miami 2019 Symposium about immunotherapy before surgery in lung cancer. He focusses on two presentations from ASCO 2019 which show that surgery is more effective after 90% of the tumour has...
This non-invasive diagnostic method could help detect the disease in its earliest stages with a small urine sample.
Kronos Bio Inc. (oncology) raised $105mm through a Series A round from investors including co-leads Viva Ventures and Omega F...
BeyondSpring Inc. netted $32.7mm through a public offering of 2mm common shares at $17. The company will use the proceeds to ...
Michel Velez, MD, provides perspective on the clinical experience with neratinib in patients with early-stage HER2-positive breast cancer as well as promising data that may lead to an indication in the metastatic setting.
Amgen and Allergan’s launch of the first biosimilars to Roche/Genentech’s Avastin and Herceptin may not face the same commercial dynamics...
A strong unmet need for survivorship care plans exists in the cancer treatment community and better follow-up is required for patients who have moved on from treatment and are experiencing its aftereffects.
Keerthi Gogineni, MD, MSHP, discusses several trials in the breast cancer field, specifically looking at de-escalation therapies.
THOUSAND OAKS, Calif., July 18, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Allergan plc(NYSE:AGN) today announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the United States (U.S.). MVASI, the first oncology therapeutic biosimilar approved by the U.S...
Iovance Biotherapeutics (NASDAQ: IOVA) has appointed Graf Finckenstein to serve as its chief medical officer. Finckenstein comes to the San Carlos, CA, cancer drug developer from Roche, where he was global head of oncology translational medicine. His experience also includes positions at Bristol-Myers Squibb (NYSE: BMY). Iovance, which is developing a type of cancer treatment […]
(Reuters Health) - Complications after skin cancer surgery may be more common in smokers and former smokers, a U.S. study suggests.
A bone cancer known as osteosarcoma is genetically similar in dogs and human children, according to the results of a new study. The findings could help break the logjam in the treatment of this deadly disease, which hasn't seen a significant medical breakthrough in nearly three decades.
Disability and death caused by preventable medical harm is equal to that caused by multiple sclerosis or cervical cancer in developed countries.
Regular consumption of fatty and lean fish was associated with about a 10% reduction in risk for CRC.
Predictive biomarkers can reduce unnecessary treatment and adverse effects unlike chemotherapy and targeted therapies which may cause toxic effects. The development of drugs using predictive biomarkers is being approved for the treatment of advanced stage non-small cell lung cancer. Predictive biomarkers will continue to gain popularity as they help in the development of cost-effective therapies ...
Jubilee Brown, MD, discusses the importance of molecular testing immediately after an ovarian cancer diagnosis and how molecular testing will shape the field of ovarian cancer.
The Essential Medicines List focuses on cancer and other global health challenges, with an emphasis on recommending effective solutions, smart prioritisation, and optimal access for patients1 The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA®) for the treatment...